Cancer cells often exhibit a phenomenon known as the Warburg effect, where they primarily rely on glycolysis for energy production, even in the presence of oxygen. However, they also utilize lipid metabolism for energy and biomass production. By inhibiting lipases, these inhibitors can starve cancer cells of essential lipids, slowing their growth and sometimes inducing cell death. This makes lipase inhibitors a valuable tool in the potential cancer treatment strategies.
